Evidence map›Paper›PMID 28740117›Full record

ReviewNature reviews. Cancer2017

Fragile sites in cancer: more than meets the eye.

Thomas W Glover, Thomas E Wilson, Martin F Arlt

Abstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
23.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 255 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Recent developments in gene therapy for Parkinson's disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thomas W GloverDepartment of Human Genetics; the Department of Pathology; and the Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Thomas E WilsonDepartment of Human Genetics; and the Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Martin F ArltDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
University of Michigan–Ann Arbor · USInstitute of Human Genetics · PL

Funding

Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genomeR01CA200731 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GLOVER, THOMAS W, WILSON, THOMAS EDWARD · 2016 to 2020
$2.4M
De novo CNV formation in vivo with sickle cell anemia therapyR01ES020875 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GLOVER, THOMAS W · 2012 to 2016
$2.0M
NCI NIH HHS R01 CA200731NIEHS NIH HHS R01 ES020875
6 · The paper itself

Abstract

Ever since initial suggestions that instability at common fragile sites (CFSs) could be responsible for chromosome rearrangements in cancers, CFSs and associated genes have been the subject of numerous studies, leading to questions and controversies about their role and importance in cancer. It is now clear that CFSs are not frequently involved in translocations or other cancer-associated recurrent gross chromosome rearrangements. However, recent studies have provided new insights into the mechanisms of CFS instability, their effect on genome instability, and their role in generating focal copy number alterations that affect the genomic landscape of many cancers.

Indexed as

Chromosomal InstabilityChromosome Fragile SitesDNA Copy Number VariationsAnaphaseAnimalsChromosome BreakageDNA Breaks, Double-StrandedDNA ReplicationGene RearrangementHumansMetaphaseNeoplasmsOncogenes

Identifiers

PMID28740117
PMCPMC5546318
OpenAlexW2739167375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.